These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 15968808

  • 21. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels.
    Stahl SM.
    J Clin Psychiatry; 2004 Jun; 65(6):738-9. PubMed ID: 15291647
    [Abstract] [Full Text] [Related]

  • 22. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders.
    Raja M, Azzoni A.
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):409-14. PubMed ID: 14604456
    [Abstract] [Full Text] [Related]

  • 23. Genetics and antiepileptic mood stabilizer treatment response in bipolar disorder: what do we know?
    Ho AM, Weinshilboum RM, Frye MA, Biernacka JM.
    Pharmacogenomics; 2021 Sep; 22(14):913-925. PubMed ID: 34486896
    [Abstract] [Full Text] [Related]

  • 24. Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy.
    Macdonald KJ, Young LT.
    CNS Drugs; 2002 Sep; 16(8):549-62. PubMed ID: 12096935
    [Abstract] [Full Text] [Related]

  • 25. Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results.
    Daban C, Martínez-Arán A, Torrent C, Sánchez-Moreno J, Goikolea JM, Benabarre A, Comes M, Colom F, Vieta E.
    J Clin Psychopharmacol; 2006 Apr; 26(2):178-81. PubMed ID: 16633148
    [Abstract] [Full Text] [Related]

  • 26. [Anticonvulsants (carbamazepine, valproate, lamotrigine) in bipolar affective disorder].
    Puzyński S.
    Psychiatr Pol; 2002 Apr; 36(6 Suppl):53-61. PubMed ID: 12647422
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and tolerability of anti-epileptic drugs-an internet study.
    Wieshmann UC, Baker G.
    Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951
    [Abstract] [Full Text] [Related]

  • 28. A cost-effectiveness decision model for antiepileptic drug treatment in newly diagnosed epilepsy patients.
    Knoester PD, Deckers CL, Termeer EH, Boendermaker AJ, Kotsopoulos IA, de Krom MC, Keyser T, Renier WO, Hekster YA, Severens HL.
    Value Health; 2007 May; 10(3):173-82. PubMed ID: 17532810
    [Abstract] [Full Text] [Related]

  • 29. Anticonvulsants in the treatment of major depressive disorder: an overview.
    Vigo DV, Baldessarini RJ.
    Harv Rev Psychiatry; 2009 May; 17(4):231-41. PubMed ID: 19637072
    [Abstract] [Full Text] [Related]

  • 30. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
    Hirschfeld RM, Kasper S.
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):507-22. PubMed ID: 15458610
    [Abstract] [Full Text] [Related]

  • 31. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations.
    Yatham LN, Kusumakar V, Calabrese JR, Rao R, Scarrow G, Kroeker G.
    J Clin Psychiatry; 2002 Apr; 63(4):275-83. PubMed ID: 12000201
    [Abstract] [Full Text] [Related]

  • 32. [Mood stabilizers--past, present and future].
    Sümegi A.
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
    [Abstract] [Full Text] [Related]

  • 33. Developments in mood stabilisers.
    Ferrier IN.
    Br Med Bull; 2001 Mar; 57():179-92. PubMed ID: 11719917
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.
    Eriksson AS, Hoppu K, Nergårdh A, Boreus L.
    Epilepsia; 1996 Aug; 37(8):769-73. PubMed ID: 8764817
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.
    Evins AE.
    J Clin Psychiatry; 2003 Aug; 64 Suppl 8():9-14. PubMed ID: 12892536
    [Abstract] [Full Text] [Related]

  • 36. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ, Lang SY, Shi XB, Tian HJ, Wang RF, Yang F.
    Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
    [Abstract] [Full Text] [Related]

  • 37. Rethinking the treatment paradigm for bipolar depression: the importance of long-term management.
    Baldassano CF, Ballas CA, O'Reardon JP.
    CNS Spectr; 2004 Sep; 9(9 Suppl 9):11-8. PubMed ID: 15361807
    [Abstract] [Full Text] [Related]

  • 38. [Lithium and anticonvulsants in bipolar depression].
    Samalin L, Nourry A, Llorca PM.
    Encephale; 2011 Dec; 37 Suppl 3():S203-8. PubMed ID: 22212876
    [Abstract] [Full Text] [Related]

  • 39. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs.
    White HS.
    Epilepsia; 1999 Dec; 40 Suppl 5():S2-10. PubMed ID: 10530688
    [Abstract] [Full Text] [Related]

  • 40. Rational polypharmacy in the bipolar affective disorders.
    Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.
    Epilepsy Res Suppl; 1996 Dec; 11():153-80. PubMed ID: 9294735
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.